These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3012223)

  • 1. [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville].
    Pineda JA; Leal M; García de Pesquera F; Sánchez-Quijano A; Rivera F; Lissen E
    Med Clin (Barc); 1986 Mar; 86(12):498-500. PubMed ID: 3012223
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence of exposure to the virus of acquired immune deficiency syndrome in risk groups from the Seville area. Preliminary evaluation].
    Leal M; Wichmann I; Ramsey R; Palmer E
    Med Clin (Barc); 1986 Jan; 86(3):130. PubMed ID: 3007883
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [No indications for LAV/HTLV-III in non-drug-using prostitutes in Amsterdam].
    Coutinho RA; van der Helm T
    Ned Tijdschr Geneeskd; 1986 Mar; 130(11):508. PubMed ID: 3008005
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human T-lymphotropic virus (HTLV-III) antibodies in intravenous drug addicts from the Valencia community].
    Rodrigo JM; Serra MA; Aguilar E; Ample I; Gimeno V; del Olmo JA; Escudero A; Aparisi L; Wassel A; Sanmartín B
    Med Clin (Barc); 1986 Jan; 86(3):89-92. PubMed ID: 3007886
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proof of diaplacental transmission of HTLV III/LAV before the 20th week of pregnancy].
    Schäfer A; Jovaisas E; Stauber M; Löwenthal D; Koch MA
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):88-9. PubMed ID: 3007265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-III antibodies in drug-addicted prostitutes used by US soldiers in Italy.
    Tirelli U; Vaccher E; Sorio R; Carbone A; Monfardini S
    JAMA; 1986 Aug; 256(6):711-2. PubMed ID: 3459900
    [No Abstract]   [Full Text] [Related]  

  • 11. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitation of and neutralizing antibodies to AIDS-retroviruses; a novel system using HTLV-I carrying MT-4 cells].
    Harada S; Yamamoto N
    Tanpakushitsu Kakusan Koso; 1985 Dec; 30(13):1394-407. PubMed ID: 3003812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevalence of antibodies against HTLV-III/LAV in subpopulations at risk of suffering the acquired immune deficiency syndrome].
    Latorre X; Gatell JM; Pumarola T; Miró JM; Laborí C; Pifarré M; Vidal J; Jiménez de Anta MT; Soriano E; Pumarola A
    Med Clin (Barc); 1986 Jan; 86(3):113-4. PubMed ID: 3457226
    [No Abstract]   [Full Text] [Related]  

  • 14. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 15. [HTLV-III infection in risk groups].
    Esteban R; Buti M; Esteban JI; Hernández JM; Jardí R; Vila M; Tusell J; Guardia J
    Med Clin (Barc); 1986 Jan; 86(3):110-2. PubMed ID: 3007880
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevalence of HTLV-III and changes in immunity in heroin addicts].
    Arribas JM; Asensi V; Pérez R; Navia-Osorio JM; Esteban J; Cartón JA; Fernández A
    Rev Clin Esp; 1985 Jul; 177(3):123-6. PubMed ID: 2997861
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain.
    Merino F; Esparza B; Aizpiri J; Fernandez J; de Masdelval L; Arrieta A; Velazquez M; Volsky DJ; San Cristobal E; de Izaguirre A
    AIDS Res; 1986; 2(2):133-40. PubMed ID: 3013221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-III antibodies in drug addicts in Spain.
    Rodrigo JM; Serra MA; Aguilar E; del Olmo JA; Gimeno V; Aparisi L
    Lancet; 1985 Jul; 2(8447):156-7. PubMed ID: 2862347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunity and drug addiction: immunologic situation in relation to the drug, HTLV-III infection and other associated infections].
    Asensi V; Cartón JA; Fernández-León A; Cárcaba V; Navia-Osorio JM; Pérez R; Diéguez MA; Arribas JM
    Med Clin (Barc); 1986 Jan; 86(3):105-9. PubMed ID: 3007879
    [No Abstract]   [Full Text] [Related]  

  • 20. False positive anti-HTLV III serology.
    Neale TJ; Dagger J; Fong R; Humble M; Meech P; Hatfield PJ; Morrison RB
    N Z Med J; 1985 Oct; 98(789):914. PubMed ID: 2997679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.